Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
Objective The modified Rodnan skin score (mRSS) is often used as a primary outcome measure in systemic sclerosis (SSc) randomized clinical trials (RCTs). Previous cohort studies with predominantly European Caucasian patients showed that setting an upper limit of mRSS as a selection criterion for RCT...
Main Authors: | Carina Mihai, Rucsandra Dobrota, Shervin Assassi, Maureen D. Mayes, Oliver Distler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11165 |
Similar Items
-
Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis
by: Caroline Evers, et al.
Published: (2021-01-01) -
Therapeutic management of fibrosis in systemic sclerosis patients – an analysis from the Swiss EUSTAR cohort
by: Kevin Windirsch, et al.
Published: (2024-02-01) -
Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
by: Shervin Assassi, et al.
Published: (2011-01-01) -
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
by: Victor Farutin, et al.
Published: (2021-10-01) -
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study
by: Ulrich A. Walker, et al.
Published: (2018-10-01)